Camden Capital, LLC Biogen Inc. Transaction History

Camden Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$222.59 - $267.94 $7,122 - $8,574	32 Added 3.5%	947 $245,000
Q3 2023 Nov 03, 2023	BUY	$253.3 - $285.89 $4,559 - $5,146	18 Added 2.01%	915 $235,000
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $246,899 - $285,299	897 New	897 $255,000
Q3 2021 Nov 03, 2021	SELL	$282.99 - $369.05 $181,679 - $236,930	-642 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $166,278 - $266,243	642 New	642 $222,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Camden Capital, LLC with notifications on news.